Chronic Myeloproliferative Disorders Terminated Phase Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00255684Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerTreatment